RCT of QPS vs General Information Sheet

Caregiver Clinical Trial

Official title:

A Randomized Controlled Trial of Two Different Information Materials in Patients With Advanced Cancer

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03287492
• Other study ID #: 2017-0028
• Secondary ID: NCI-2018-0105220
• Status: Active, not recruiting
• Phase: N/A
• Start date: September 25, 2017
• Est. completion date: December 31, 2024

Study information

• Verified date: April 2024
• Source: M.D. Anderson Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This trial studies how well information materials work in helping communication between physicians and participants with cancer that has spread to other places in the body and their caregivers. Approaches that encourage participants to actively participate and ask appropriate questions during their visit may be important to enhance their understanding of their illness and empower them to make important decisions regarding their medical care.

Description:

PRIMARY OBJECTIVES:

I. To compare patients' perception of helpfulness in communicating with their physicians between a question prompt sheet (QPS) and a general information sheet (GIS).

SECONDARY OBJECTIVES:

I. To compare caregivers' perception of helpfulness in communicating with their physicians between the QPS and the GIS.

II. To examine the level of patients' and caregivers' overall satisfaction with the consultation with the use of the QPS versus the GIS.

III. To examine physicians' views about the information material and overall satisfaction with the use of the QPS versus the GIS.

IV. To explore how the use of QPS affects the average speaking time of patient or physician during the consultation visit.

V. To establish demographic and clinical predictors of patients' perception of helpfulness of a QPS.

VI. To examine the overall patients' preference between the QPS and GIS in an open label phase.

VII. To compare the change in patient anxiety state with the use of the QPS versus the GIS.

VIII. To explore the factors underlying patients' preferences for the QPS or GIS.

OUTLINE: Participants are randomized into 1 of 2 groups.

GROUP I: Participants receive QPS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

GROUP II: Participants receive GIS and answer questions from physician. At follow up visit, participants receive both QPS and GIS.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 207
• Est. completion date: December 31, 2024
• Est. primary completion date: December 31, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• (Patient participation) First outpatient consultation visit with a palliative care specialist

• (Patient participation) Normal cognitive status, defined as a normal state of arousal and an absence of obvious clinical findings of confusion, memory deficits or concentration deficits, as determined by the patient's physician

• (Patient participation) Ability to read and communicate in English

• (Patient participation) Diagnosis of advanced cancer

• (Patient participation) Signed written informed consent form

• (Caregiver participation) accompanied the patient to the clinic visit

• (Caregiver participation) is identified by the patient as someone who is actively involved in their overall care

• (Caregiver participation) is able to read and communicate in English

• (Caregiver participation) is willing to participate in the study and able to complete the questionnaires

• (Physician participation) a palliative medicine specialist

• (Physician participation) seeing the patient in consultation on the day of the study

• (Physician participation) willing to participate in the study

Exclusion Criteria:

• Refusal to participate in the study

Related Conditions & MeSH terms

• Advanced Malignant Neoplasm
• Caregiver
• Neoplasms
• Physician

Intervention

Other:
• Informational Intervention
Receive QPS
• Informational Intervention
Receive GIS
• Questionnaire Administration
Ancillary studies

Locations

Country	Name	City	State
United States	M D Anderson Cancer Center	Houston	Texas

Sponsors (2)

Lead Sponsor	Collaborator
M.D. Anderson Cancer Center	National Cancer Institute (NCI)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patients' perception of helpfulness (0-10 scale) in communicating with their physicians after the first consultation visit	Standard statistics including mean, standard deviation, median, range, frequency and percentage will be summarized for variables of interest, such as patients' demographics, clinical characteristics, anxiety state, patients'/caregivers' views about the information material, patients' satisfaction, physicians' views about the information material and consultation, patients' preferences for information, patient preferences for level of involvement in decision-making and patients' overall preference between the question prompt sheet (QPS) and the general information sheet (GIS) at the follow-up visit. Two sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used to compare continuous variables of interest between the QPS and the GIS. Chi-squared test or Fisher's exact test, whichever appropriate, will be used to test for associations between categorical variables and helpfulness of information material.	Up to 3 years
Secondary	Caregivers' perception of helpfulness in communicating with their physicians	Sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used.	Up to 3 years
Secondary	Patients'/caregivers' overall satisfaction with the consultation	Sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used.	Up to 3 years
Secondary	Physician's view/overall satisfaction about the information material	Sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used.	Up to 3 years
Secondary	Change in patient anxiety state scores before and after consultation between the QPS and the GIS	Sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used.	Baseline up to 6 weeks
Secondary	Average speaking time of patient or physician during the consultation visit affected by QPS	Two sample t-test or Wilcoxon rank sum test, whichever appropriate, will be used to compare the average speaking time of patient or physician during the consultation visit. Also, general linear model will be applied to assess the effect of QPS on the average speaking time adjusting for clinically and/or statistically important factors.	Up to 3 years
Secondary	Demographic and clinical predictors of patients' perception of helpfulness of a QPS	Univariate/multicovariate logistic regression will be used to evaluate patients' demographic and clinical factors on patients' perception of helpfulness of QPS when dichotomizing the answer to the question 3 in the Patient/Caregiver Assessment Questionnaire ("Agree/Strongly Agree"=Helpful versus the rest).	Up to 3 years
Secondary	Overall patients' preference between the QPS and GIS in an open label phase	Will estimate the preference of information material with 95% confidence intervals. Also, univariate/multicovariate logistic regression will be used to evaluate patients' demographic and clinical factors on overall patients' preference between QPS and GIS.	Up to 3 years

External Links

•   University of Texas MD Anderson Cancer Center Website